Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-07-26

Clinical Trial Update: Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk [Phase 1]

View source ↗

Summary

Phase 1 study assessing whether Plantago ovata husk fiber can modify the pharmacokinetic profile of levodopa in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psyllium husk (psyllium husk)
  • levodopa (levodopa)

Snippet

Sponsor: Rottapharm Spain | Conditions: Parkinson's Disease, Idiopathic | Phase 1 | Status: COMPLETED